Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Pharmaceutical

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals' headquarters in Cambridge, MA, United States

The Norton office focuses on manufacturing, quality control, and operational support for scientific and commercial initiatives.

Norton

The Zug office focuses on international medical affairs, events, compliance, and strategic analytics in the healthcare sector.

Yvonne Greenstreet

Christine Lindenboom

Pushkal Garg

Mike Tirozzi

Melissa Mclaughlin

Gabriel Robbie

Timothy Maines

Jeff Poulton

Bryan Supran

Kevin Fitzgerald

John Gansner

Tara Smith

Yutaka Okada

Vasant Jadhav

Brett Budzinski

Tolga Tanguler

Dennis A. Ausiello

Margaret A. Hamburg

Olivier Brandicourt

Elliott Sigal

Peter N. Kellogg

David E.i. Pyott

Colleen Reitan

Amy W. Schulman

Stuart A. Arbuckle

This department focuses on research and development in biological sciences, including the study and analysis of various scientific disciplines related to biology.

Biological Sciences

This department focuses on identifying growth opportunities and managing regional business strategies.

Business Development

The Clinical Operations team at Alnylam Pharmaceuticals is essential for overseeing the planning, execution, and management of clinical trials for RNAi therapeutics. This team collaborates closely on trial design, data management, and regulatory compliance to ensure the effectiveness and safety of innovative treatments. Their comprehensive expertise supports the company's mission to develop groundbreaking medicines, while optimizing operational efficiency and maintaining high standards in clinical research.

Clinical Operations

This department focuses on ensuring the quality and compliance of products and services through systematic processes, documentation, and validation efforts.

Quality Assurance

This department focuses on managing and nurturing relationships with key clients to ensure their needs are met and to drive business growth.

Key Account Management

The Regulatory Affairs and Compliance team at Alnylam Pharmaceuticals is responsible for ensuring that all RNAi therapeutics meet stringent regulatory requirements while maintaining high ethical standards. This team collaborates closely with global regulatory bodies to navigate approval processes, oversees pharmacovigilance and quality assurance, and implements compliance strategies to safeguard patient safety and uphold the company’s commitment to excellence in therapeutics.

Alnylam Pharmaceuticals

Org chart

Board & advisors

Teams

Biological Sciences

Business Development

Clinical Operations

Quality Assurance

Key Account Management

Regulatory Affairs and Compliance

Offices

Alnylam Pharmaceuticals

Org chart

Board & advisors

Teams

Biological Sciences

Business Development

Clinical Operations

Quality Assurance

Key Account Management

Regulatory Affairs and Compliance

Offices

Related companies